Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Protein Shift Predicts Brain Cancer Grade, Recurrence and Patient Survival

22.06.2004


Study results published in the August issue of the journal Cancer reinforce previous findings that the laminin-8 genes and the resulting protein may be highly valuable targets in the fight against malignant brain tumors.

Researchers at Cedars-Sinai’s Maxine Dunitz Neurosurgical Institute report that over-expression of laminin-8 can be used as a predictor of a tumor’s grade, its potential for recurrence, and the patient’s length of survival. This follows their earlier findings that laminin-8 is up-regulated in the most aggressive brain tumors, glioblastoma multiforme (GBM), and that the gene promotes the tumor cells’ ability to invade neighboring tissue.

The thin “basement membrane” that lies beneath the surface layer of blood vessels contains proteins called laminins. Fifteen laminins have been identified to date. The Cedars-Sinai researchers found that during tumor progression, laminin-9, which is expressed weakly in normal brain tissue and low-grade glial tumors, switched to laminin-8, and the level of expression of the laminin-8 increased significantly, depending on brain tumor grade.



Gliomas develop from glial cells, which make up the supportive tissue of the brain. Different forms of gliomas are further classified by their specific cells of origin and characteristics. The average survival time for patients with Grade 1 or Grade 2 gliomas is six to eight years. For anaplastic astrocytomas (Grade 3 gliomas), survival time decreases to three years, and for Grade 4 astrocytomas, called glioblastoma multiforme (GBM), survival length typically ranges from 12 to 18 months. GBM cells proliferate uncontrollably, aggressively infiltrating nearby tissue. As a GBM progresses, portions of the tumor often outgrow the blood supply but new blood vessels form. The development of these new vessels, a process called angiogenesis, enables the tumor to grow unchecked.

In this study, Cedars-Sinai researchers, in conjunction with colleagues in Japan, Sweden and Germany, analyzed a variety of gliomas of both high and low grades, as well as normal brain tissue samples. Low-grade astrocytomas and normal brain tissue were found to express very low levels of laminin-9 and virtually no laminin-8. The levels of expression of both variants increased in Grade 3 gliomas, and as gliomas progressed to Grade 4, laminin-8 expression increased significantly and laminin-9 levels tended to decline.

The particular isoform (laminin-8 or laminin-9) predominantly expressed in Grade 4 gliomas appeared to correlate with time to recurrence after tumor-removal surgery. Among patients with high laminin-8 expression, tumors recurred about 4 months after surgery, compared with more than 11 months among patients whose tumors expressed laminin-9 predominantly. Patients with higher levels of laminin-8 also had shorter lengths of survival, averaging about 11 months, compared to 16.7 months when laminin-9 was predominant.

“Historically, the diagnosis of glioblastoma multiforme has come with an extremely poor prognosis, and traditional treatments have had very limited impact on patient survival,” said Keith L. Black, MD, director of the Maxine Dunitz Neurosurgical Institute, Cedars-Sinai’s Division of Neurosurgery and the Comprehensive Brain Tumor Program.

“Only in recent years have we begun to see progress, which is coming from a better understanding of genetic, molecular and immunologic changes that enable these deadly tumors to grow,” said Dr. Black, who holds the Ruth and Lawrence Harvey Chair in Neuroscience at the medical center. “Although a number of genes and proteins have been identified as having altered expression in glial tumors, few have become reliable indicators that can be used to improve diagnosis, prognosis and treatment.”

Julia Y. Ljubimova, MD, PhD, research scientist at the Institute and first author of the Cancer article, said the over-expression of laminin-8 may prove to be one of those important markers. Taken in consideration with other genes known to support tumor growth, it may give clinicians measurable clues for predicting recurrence and survival times of patients with high-grade gliomas.

“The switch from laminin-9 to laminin-8 expression, with its gradual increase from a low level of expression in low-grade tumors to a moderate level of expression in Grade 3 gliomas to a significantly high level of expression in 74 percent of GBMs, may be associated with the development of new tumor-feeding blood vessels, contributing to tumor aggressiveness,” she said. “Therefore, laminin-8 appears to be a promising marker of tumor progression. Perhaps more importantly, we hypothesize that if laminin-8 plays a major role in tumor progression and recurrence, it could be an important target for the development of new therapies.”

Cedars-Sinai is one of the largest nonprofit academic medical centers in the Western United States. For the fifth straight two-year period, it has been named Southern California’s gold standard in health care in an independent survey. Cedars-Sinai is internationally renowned for its diagnostic and treatment capabilities and its broad spectrum of programs and services, as well as breakthroughs in biomedical research and superlative medical education. It ranks among the top 10 non-university hospitals in the nation for its research activities.

Sandy Van | Cedars-Sinai
Further information:
http://www.csmc.edu

More articles from Studies and Analyses:

nachricht Study relating to materials testing Detecting damages in non-magnetic steel through magnetism
23.07.2018 | Technische Universität Kaiserslautern

nachricht Innovative genetic tests for children with developmental disorders and epilepsy
11.07.2018 | Christian-Albrechts-Universität zu Kiel

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: It’s All in the Mix: Jülich Researchers are Developing Fast-Charging Solid-State Batteries

There are currently great hopes for solid-state batteries. They contain no liquid parts that could leak or catch fire. For this reason, they do not require cooling and are considered to be much safer, more reliable, and longer lasting than traditional lithium-ion batteries. Jülich scientists have now introduced a new concept that allows currents up to ten times greater during charging and discharging than previously described in the literature. The improvement was achieved by a “clever” choice of materials with a focus on consistently good compatibility. All components were made from phosphate compounds, which are well matched both chemically and mechanically.

The low current is considered one of the biggest hurdles in the development of solid-state batteries. It is the reason why the batteries take a relatively long...

Im Focus: Color effects from transparent 3D-printed nanostructures

New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference

Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

 
Latest News

Quantum bugs, meet your new swatter

20.08.2018 | Information Technology

A novel synthetic antibody enables conditional “protein knockdown” in vertebrates

20.08.2018 | Life Sciences

Metamolds: Molding a mold

20.08.2018 | Information Technology

VideoLinks
Science & Research
Overview of more VideoLinks >>>